Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Healthcare ETF

73.84
-0.0500-0.07%
Volume:274.32K
Turnover:20.23M
Market Cap:3.91B
PE:6.65
High:73.96
Open:73.82
Low:73.34
Close:73.89
52wk High:74.59
52wk Low:56.44
Shares:52.95M
Float Shares:52.95M
Volume Ratio:0.55
T/O Rate:0.52%
Dividend:0.81
Dividend Rate:1.10%
EPS(TTM):11.10
EPS(LYR):3.06
ROE:6.01%
ROA:0.87%
PB:1.40
PE(LYR):24.14

Loading ...

Pharma Stocks Have Rallied. 2 Stocks to Avoid-and 2 to Buy.

Dow Jones
·
Aug 21

Johnson & Johnson Says Multiple Myeloma Treatment Approved by European Commission

MT Newswires Live
·
Aug 21

African Markets - Factors to Watch on Aug 21

Reuters
·
Aug 21

Moderna’s Personalized MRNA Shot Could Reshape the Fight Against Skin Cancer — but It May Also Be Overhyped

Dow Jones
·
Aug 21

My Son Does not Work, yet Pays $500 for Affordable Care Act Health Insurance. is That Fair?

Dow Jones
·
Aug 21

Perrigo Co. PLC Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 21

Does J&J’s MONARCH QUEST 3 Approval and MedTech Momentum Change The Bull Case For Johnson & Johnson (JNJ)?

Simply Wall St.
·
Aug 21

Thursday's Top 20 US Stock Transactions: Micron Rises 3.97% Following $10 Billion Research Lab Announcement

Deep News
·
Aug 21

Moderna is up 350% Since Our Recommendation. Here's What to Do Next.

Dow Jones
·
Aug 21

Sector Update: Healthcare Stocks Fall Thursday Afternoon

MT Newswires Live
·
Aug 21

Exchange-Traded Funds Fall as US Equities Decline After Midday

MT Newswires Live
·
Aug 21

Congo Set to Receive 70,000 Ervebo Vaccines to Contain Ebola Outbreak, WHO Says

Reuters
·
Aug 21

Gavi Announces $7 Mln Funding for Shipment of 70,000 Doses of Ervebo Vaccine to DRC

Reuters
·
Aug 21

Merck Stock (MRK) Is a Strong Buy Now as 3 Top Wall Street Analysts Hike Price Targets

TIPRANKS
·
Aug 21

AbbVie Targets Next-Gen BOTOX Combo With New Glabellar Lines Study

TIPRANKS
·
Aug 21

Eli Lilly Advances Early-Stage Eloralintide Trial: What Investors Should Watch

TIPRANKS
·
Aug 21

Eli Lilly’s Lebrikizumab Trial Completion Signals New Growth Path in Atopic Dermatitis

TIPRANKS
·
Aug 21

Merck is Maintained at Buy by UBS

Dow Jones
·
Aug 21

Why Merck Stock Got Downgraded After a Massive Cancer-Vaccine Win

Dow Jones
·
Aug 20

Merck's Momentum Remains Strong But Valuation Limits Further Upside, RBC Says

MT Newswires Live
·
Aug 20